Michael A. Swit, Esq., has solved vital FDA legal issues since 1984, with a focus on drug and device challenges. Before joining Illumina as its senior regulatory counsel in December 2014, he was a Special Counsel in the FDA Law Practice at Duane Morris, a global law firm. He also served for seven years as a VP at The Weinberg Group, a prominent FDA consulting firm; was with several major FDA law firms; general counsel of Par Pharmaceutical; and was CEO of FDANews, a premier FDA regulatory publisher. A magna cum laude graduate of Bowdoin College, he got his law degree at Emory University and is a member of the California bar.